CYCLIC NUCLEOTIDES, CYCLOPHOSPHAMIDES, BIOPHOSPHONATES
环状核苷酸、环磷酰胺、二磷酸盐
基本信息
- 批准号:2192659
- 负责人:
- 金额:$ 24.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1975
- 资助国家:美国
- 起止时间:1975-06-01 至 1999-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Research is proposed in four diverse but related areas. One long range
goal is a better understanding of the role of cyclic nucleotides (cAMP in
particular and also cGMP) in cell proliferation and maligant
transformation through a detailed knowledge of their interactions with
key enzymes, protein kinase (PK-1 and PK-2) and various
phosphodiesterases. NMR studies of the phosphate ring conformation and
phosphorus covalency in model enzyme-cyclic nucleotide systems and of
cAMP-PK adducts themselves will be pursued. The influence of
stereoelectronic effects on chair-twist equilibria of the phosphate ring
will be assessed by 1 H NMR. New synthetic investigations of neutral
cyclic nucleotide derivatives are aimed at: 1) prodrug delivery of known
or potential antivirals and antitumor agents, with a focus on previously
targeted thymidylate synthase in thymidine kinase-deficient drug-
resistant HSV-1 mutants; and, 2) potential cAMP or cGMP
antagonist/agonist molecules for study in Dictyostelium discoideum/cAMP
receptor protein systems and with cGMP-activated phosphodiesterases.
Biological activities will be determined collaboratively. Certain P
(III)-containing cyclic nucleotides will serve as precursors to models
with valuable biological properties or useful in dinucleotide synthesis.
A thorough knowledge of the conformational properties of the 1,3,1-
oxazaphosphorinane ring system of the clinically valuable antitumor agent
cyclophosphamide will be pursued as a partial basis for understanding its
activity and the design of improved drugs. Specifically, NMR and X-ray
crystallographic studies should yield knowledge of the influence of
stereoelectronic effects in determining conformation. Detailed knowledge
of the scope and mechanism of the formation of azetidines from certain
1,3,2-oxazaphosphorinanes will be sought. The eventual target is
biologically active azetidinones.
17 O NMR studies will be aimed at the non-degradative correlation of 17 0
spectral parameters with phosphorus configuration in biologically
important P-chiral nucleoside-derived phosphate triesters, phosphonates,
and phosphoramidates.
A new phosphite to phosphonate photo-Arbuzov rearrangement will be
applied to the synthesis of novel antivirals based on acyclic nucleosides
and 2',3'-dideoxy- and 2',3'-didehydro-2, 3' -dideoxy ribonucleosides.
The focus is on antivirals active against a broad spectrum of viruses
including HIV.
在四个不同但相关的领域提出了研究。 一个远距离
目标是更好地理解环核苷酸的作用(在
细胞增殖和不良的特殊和CGMP)
通过详细了解他们与
关键酶,蛋白激酶(PK-1和PK-2)和各种
磷酸二酯酶。 NMR的磷酸环构象和
模型酶循环核苷酸系统中的磷共价和
Camp-PK加合物本身将被追捕。 影响
立体电子对磷酸环的椅子扭转平衡的影响
将通过1 H NMR评估。 中性的新合成研究
环状核苷酸衍生物的目的是:1)
或潜在的抗病毒药和抗肿瘤剂,重点是
胸苷激酶缺乏药物的靶向胸苷合酶 -
抗性HSV-1突变体; 2)潜在的营地或CGMP
用于研究dictyostelium discoideum/CAMP的拮抗剂/激动剂分子
受体蛋白系统和CGMP激活的磷酸二酯酶。
生物活动将由协作确定。 某些p
(iii) - 含有循环核苷酸将作为模型的前体
具有有价值的生物学特性或用于二核苷酸合成。
对1,3,1-的构象性质有透彻的了解
临床上有价值的抗肿瘤剂的奥沙唑磷素环系统
环磷酰胺将被作为理解其部分的部分基础
活性和改进药物的设计。 具体而言,NMR和X射线
晶体学研究应得出有关影响的知识
立体电代效应在确定构象中。 详细的知识
从某些的
将寻求1,3,2-氧气磷酸磷酸。 最终的目标是
生物活性氮杂季酮。
17 O NMR研究将针对17 0的非降解相关性
生物学上具有磷构型的光谱参数
重要的p-手续核苷衍生的磷酸三角体,磷酸盐,,
和磷酰胺。
一种新的磷酸盐磷酸磷酸盐照片 - 阿布佐夫重排将是
应用于基于无环核苷的新型抗病毒药的合成
以及2',3'-二维和2',3'-二氢-2,3' - 二氧核糖核苷。
重点是针对广泛病毒的抗病毒药
包括艾滋病毒。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
WESLEY G BENTRUDE的其他基金
CYCLIC NUCLEOTIDES, CYCLOPHOSPHAMIDES, AND ANTIVIRALS
环核苷酸、环磷酰胺和抗病毒药
- 批准号:31634393163439
- 财政年份:1975
- 资助金额:$ 24.92万$ 24.92万
- 项目类别:
CYCLIC NUCLEOTIDES, CYCLOPHOSPHAMIDES, BIOPHOSPHONATES
环状核苷酸、环磷酰胺、二磷酸盐
- 批准号:21926602192660
- 财政年份:1975
- 资助金额:$ 24.92万$ 24.92万
- 项目类别:
CYCLIC NUCLEOTIDES, CYCLOPHOSPHAMIDES, BIOPHOSPHONATES
环状核苷酸、环磷酰胺、二磷酸盐
- 批准号:23922562392256
- 财政年份:1975
- 资助金额:$ 24.92万$ 24.92万
- 项目类别:
CYCLIC NUCLEOTIDES, CYCLOPHOSPHAMIDES, AND ANTIVIRALS
环核苷酸、环磷酰胺和抗病毒药
- 批准号:31634383163438
- 财政年份:1975
- 资助金额:$ 24.92万$ 24.92万
- 项目类别:
CYCLIC NUCLEOTIDE AND CYCLOPHOSPHAMIDE DERIVATIVES
环核苷酸和环磷酰胺衍生物
- 批准号:31634353163435
- 财政年份:1975
- 资助金额:$ 24.92万$ 24.92万
- 项目类别:
CYCLIC NUCLEOTIDES, CYCLOPHOSPHAMIDES, AND ANTIVIRALS
环核苷酸、环磷酰胺和抗病毒药
- 批准号:31634313163431
- 财政年份:1975
- 资助金额:$ 24.92万$ 24.92万
- 项目类别:
CYCLIC NUCLEOTIDE AND CYCLOPHOSPHAMIDE DERIVATIVES
环核苷酸和环磷酰胺衍生物
- 批准号:31634333163433
- 财政年份:1975
- 资助金额:$ 24.92万$ 24.92万
- 项目类别:
CYCLIC NUCLEOTIDES, CYCLOPHOSPHAMIDES, AND ANTIVIRALS
环核苷酸、环磷酰胺和抗病毒药
- 批准号:31634373163437
- 财政年份:1975
- 资助金额:$ 24.92万$ 24.92万
- 项目类别:
CYCLIC NUCLEOTIDE AND CYCLOPHOSPHAMIDE DERIVATIVES
环核苷酸和环磷酰胺衍生物
- 批准号:31634343163434
- 财政年份:1975
- 资助金额:$ 24.92万$ 24.92万
- 项目类别:
CYCLIC NUCLEOTIDES, CYCLOPHOSPHAMIDES, BIOPHOSPHONATES
环状核苷酸、环磷酰胺、二磷酸盐
- 批准号:26850782685078
- 财政年份:1975
- 资助金额:$ 24.92万$ 24.92万
- 项目类别:
相似海外基金
CYCLIC NUCLEOTIDES, CYCLOPHOSPHAMIDES, AND ANTIVIRALS
环核苷酸、环磷酰胺和抗病毒药
- 批准号:31634393163439
- 财政年份:1975
- 资助金额:$ 24.92万$ 24.92万
- 项目类别:
CYCLIC NUCLEOTIDES, CYCLOPHOSPHAMIDES, BIOPHOSPHONATES
环状核苷酸、环磷酰胺、二磷酸盐
- 批准号:23922562392256
- 财政年份:1975
- 资助金额:$ 24.92万$ 24.92万
- 项目类别:
CYCLIC NUCLEOTIDES, CYCLOPHOSPHAMIDES, AND ANTIVIRALS
环核苷酸、环磷酰胺和抗病毒药
- 批准号:31634383163438
- 财政年份:1975
- 资助金额:$ 24.92万$ 24.92万
- 项目类别:
CYCLIC NUCLEOTIDES, CYCLOPHOSPHAMIDES, BIOPHOSPHONATES
环状核苷酸、环磷酰胺、二磷酸盐
- 批准号:26850782685078
- 财政年份:1975
- 资助金额:$ 24.92万$ 24.92万
- 项目类别:
CYCLIC NUCLEOTIDES, CYCLOPHOSPHAMIDES, AND ANTIVIRALS
环核苷酸、环磷酰胺和抗病毒药
- 批准号:20859422085942
- 财政年份:1975
- 资助金额:$ 24.92万$ 24.92万
- 项目类别: